https://scholars.lib.ntu.edu.tw/handle/123456789/548777
標題: | Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis | 作者: | Bhatia D. KUEI-PIN CHUNG Nakahira K. Patino E. Rice M.C. Torres L.K. Muthukumar T. Choi A.M.K. Akchurin O.M. Choi M.E. |
公開日期: | 2019 | 卷: | 4 | 期: | 23 | 來源出版物: | JCI Insight | 摘要: | Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining kidney function and is impaired in pathologic states. Macrophages are well known for their pathogenic role in kidney fibrosis. Here, we report that PINK1/Parkin-mediated mitophagy in macrophages is compromised in experimental and human kidney fibrosis. We demonstrate downregulation of mitophagy regulators mitofusin-2 (MFN2) and Parkin downstream of PINK1 in kidney fibrosis. Loss of either Pink1 or Prkn promoted renal extracellular matrix accumulation and frequency of profibrotic/M2 macrophages. Pink1-/- or Prkn-/- BM-derived macrophages (BMDMs) showed enhanced expression of rictor. Mitochondria from TGF-β1-treated Pink1-/- BMDMs exhibited increased superoxide levels, along with reduced respiration and ATP production. In addition, mitophagy in macrophages involves PINK1-mediated phosphorylation of downstream MFN2, MFN2-facilitated recruitment of Parkin to damaged mitochondria, and macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Moreover, mitophagy regulators were downregulated in human CKD kidney and TGF-β1-treated human renal macrophages, whereas Mdivi1 treatment suppressed mitophagy mediators and promoted fibrotic response. Taken together, our study is the first to our knowledge to demonstrate that macrophage mitophagy plays a protective role against kidney fibrosis via regulating the PINK1/MFN2/Parkin-mediated pathway. ? 2019, American Society for Clinical Investigation. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/548777 | ISSN: | 2379-3708 | DOI: | 10.1172/jci.insight.132826 | SDG/關鍵字: | adenosine triphosphate; alpha smooth muscle actin; cell protein; chemokine receptor CX3CR1; fibronectin; mannose receptor; mitofusin 2; parkin; phosphatase and tensin homolog induced kinase 1; protein serine threonine kinase; recombinant transforming growth factor beta1; rictor; superoxide; transforming growth factor beta1; unclassified drug; adenosine triphosphate; guanosine triphosphatase; MFN2 protein, human; Mfn2 protein, mouse; mitochondrial protein; parkin; protein kinase; PTEN-induced putative kinase; transcriptome; ubiquitin protein ligase; adult; animal cell; animal experiment; animal model; animal tissue; Article; bone marrow derived macrophage; controlled study; down regulation; extracellular matrix; female; gene deletion; human; human cell; kidney fibrosis; macrophage; male; middle aged; mitochondrial membrane potential; mitochondrial respiration; mitochondrion; mitophagy; mouse; nonhuman; nuclear reprogramming; protein expression; protein phosphorylation; protein synthesis; protein transport; renal protection; adolescent; animal; child; fibrosis; genetics; kidney; kidney disease; knockout mouse; macrophage; metabolism; mitophagy; pathology; phosphorylation; physiology; THP-1 cell line; Adenosine Triphosphate; Adolescent; Adult; Animals; Child; Female; Fibrosis; GTP Phosphohydrolases; Humans; Kidney; Kidney Diseases; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitophagy; Phosphorylation; Protein Kinases; THP-1 Cells; Transcriptome; Ubiquitin-Protein Ligases |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。